Xiao‐Wu Chen

1.6k total citations
32 papers, 1.1k citations indexed

About

Xiao‐Wu Chen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Xiao‐Wu Chen has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Surgery. Recurrent topics in Xiao‐Wu Chen's work include Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Microtubule and mitosis dynamics (3 papers). Xiao‐Wu Chen is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Microtubule and mitosis dynamics (3 papers). Xiao‐Wu Chen collaborates with scholars based in China, United States and Australia. Xiao‐Wu Chen's co-authors include Damian J. McColl, Willard Lew, Shu‐Feng Zhou, Guoxin Wang, Xueji Zhang, Dajian Zhu, Yong Yang, Kevin Sneed, Tianxin Yang and Zhixu He and has published in prestigious journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy and World Journal of Gastroenterology.

In The Last Decade

Xiao‐Wu Chen

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao‐Wu Chen China 16 575 210 205 186 176 32 1.1k
Juan J. Martínez‐Irujo Spain 20 451 0.8× 138 0.7× 127 0.6× 125 0.7× 111 0.6× 39 966
Chenglai Xia China 24 691 1.2× 108 0.5× 193 0.9× 131 0.7× 68 0.4× 61 1.4k
Linda Bertoncelli Italy 12 506 0.9× 58 0.3× 108 0.5× 102 0.5× 140 0.8× 16 1.2k
Shwu-Huey Liu United States 15 494 0.9× 204 1.0× 204 1.0× 230 1.2× 80 0.5× 25 1.1k
Hirotsugu Ueda Japan 16 1.0k 1.8× 49 0.2× 410 2.0× 76 0.4× 149 0.8× 29 1.8k
John M. Hilfinger United States 22 641 1.1× 297 1.4× 507 2.5× 137 0.7× 55 0.3× 44 1.5k
Michel Garneau Canada 21 495 0.9× 289 1.4× 113 0.6× 339 1.8× 100 0.6× 57 1.3k
Olaf Kinzel Italy 17 389 0.7× 122 0.6× 345 1.7× 203 1.1× 72 0.4× 42 964
Alexander A. Chumanevich United States 24 989 1.7× 72 0.3× 419 2.0× 146 0.8× 40 0.2× 46 1.8k

Countries citing papers authored by Xiao‐Wu Chen

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Wu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Wu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Wu Chen more than expected).

Fields of papers citing papers by Xiao‐Wu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Wu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Wu Chen. The network helps show where Xiao‐Wu Chen may publish in the future.

Co-authorship network of co-authors of Xiao‐Wu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Wu Chen. A scholar is included among the top collaborators of Xiao‐Wu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Wu Chen. Xiao‐Wu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Xiubo, et al.. (2024). Discovery of macrocyclic covalent inhibitors for severe acute respiratory syndrome coronavirus 2 3CL protease. Bioorganic & Medicinal Chemistry. 111. 117846–117846. 1 indexed citations
2.
Xiong, Man, et al.. (2022). MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer. Journal of Oncology. 2022. 1–17. 8 indexed citations
3.
Yang, Yong, Guoxin Wang, Dajian Zhu, et al.. (2017). Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer. International Journal of Oncology. 51(2). 515–524. 41 indexed citations
4.
Chen, Xiao‐Wu, et al.. (2016). A Comparison of Non-Human Primate Cytochrome P450 2D Members and the Implication in Drug Discovery. Current Drug Metabolism. 17(6). 520–527. 3 indexed citations
5.
Li, Zhiling, et al.. (2016). An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor. Clinical and Experimental Pharmacology and Physiology. 43(6). 585–601. 36 indexed citations
6.
Zhou, Shu-Feng, Juanjuan Yin, Yinxue Yang, et al.. (2015). Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study. Drug Design Development and Therapy. 9. 4441–4441. 25 indexed citations
7.
Zhu, Dajian, Xiao‐Wu Chen, Manzhao Ouyang, & Yan Lu. (2015). Three surgical planes identified in laparoscopic complete mesocolic excision for right-sided colon cancer. World Journal of Surgical Oncology. 14(1). 7–7. 13 indexed citations
8.
Li, Jin-Ping, Qilun Liu, Zhixue He, et al.. (2015). The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells. Drug Design Development and Therapy. 9. 1027–1027. 30 indexed citations
10.
Wang, Weidong, Jie Lin, Zhiqiang Wu, et al.. (2015). Partial splenectomy using a laparoscopic bipolar radiofrequency device: A case report. World Journal of Gastroenterology. 21(11). 3420–3424. 11 indexed citations
11.
Chen, Xiao‐Wu, et al.. (2013). Beclin 1 and nuclear factor-κBp65 are upregulated in hepatocellular carcinoma. Oncology Letters. 5(6). 1813–1818. 11 indexed citations
12.
Chen, Xiao‐Wu, et al.. (2012). [Adenovirus vector mediated human 14-3-3 γ gene transfer protects dopaminergic cells against rotenone-induced injury].. PubMed. 92(1). 55–9. 1 indexed citations
13.
Chen, Xiao‐Wu & Shu Zhou. (2012). Can we Avoid Unfavourable Clinical Herb-Drug Interactions?. 1(S1). 1 indexed citations
14.
Chen, Xiao‐Wu, et al.. (2011). Herbal bioactivation, molecular targets and the toxicity relevance. Chemico-Biological Interactions. 192(3). 161–176. 74 indexed citations
15.
McColl, Damian J. & Xiao‐Wu Chen. (2009). Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy. Antiviral Research. 85(1). 101–118. 136 indexed citations
16.
Tsiang, Manuel, G.S. Jones, Magdeleine Hung, et al.. (2009). Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex. Journal of Biological Chemistry. 284(48). 33580–33599. 40 indexed citations
17.
Chen, Xiao‐Wu, et al.. (2006). Overexpression of 14-3-3 protein protects pheochromocytoma cells against 1-methyl-4-phenylpyridinium toxicity.. PubMed. 22(5). 281–7. 7 indexed citations
18.
Fang, Chihua, et al.. (2005). [Value of magnetic resonance angiography combined with magnetic resonance cholangiopancreatography on diagnosis for patients with carcinoma of head of pancreas].. PubMed. 43(21). 1379–82. 3 indexed citations
19.
Li, Jimmy C. M., et al.. (2003). Unusual Presentations of Hepatic Clonorchiasis. Gastrointestinal Endoscopy. 58(4). 637–639. 1 indexed citations
20.
Lew, Willard, et al.. (2000). Discovery and Development of GS 4104 (oseltamivir) An Orally Active Influenza Neuraminidase Inhibitor. Current Medicinal Chemistry. 7(6). 663–672. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026